These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1155530)

  • 1. Mid-trimester abortion induced by intravaginal administration of prostaglandin E2 suppositories.
    Lauersen NH; Secher NJ; Wilson KH
    Am J Obstet Gynecol; 1975 Aug; 122(8):947-54. PubMed ID: 1155530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
    Bolognese RJ; Corson SL
    Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 induction of abortion and fetal demise.
    Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
    Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midtrimester abortion induced by serial intramuscular injections of 15(S)-15-methyl-prostaglandin E2 methyl ester.
    Lauersen NH; Secher NJ; Wilson KH
    Am J Obstet Gynecol; 1975 Dec; 123(7):665-70. PubMed ID: 1200057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midtrimester abortion induced by single intra-amniotic instillation of two dose schedules of 15(S)-15-methyl-prostaglandin F2alpha.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Apr; 9(4):617-25. PubMed ID: 1153812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of intrauterine fetal death with prostaglandin E2 vaginal suppositories.
    Lauersen NH; Cederqvist LL; Wilson KH
    Am J Obstet Gynecol; 1980 Aug; 137(7):753-7. PubMed ID: 7405965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of midtrimester abortion by serial intravaginal administration of 15(S)-15-methyl-prostaglandin F2alpha (THAM) suppositories.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Dec; 10(6):1037-45. PubMed ID: 1208882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
    Bygdeman M; Christensen N; Gréen K; Lundström V
    Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a 10 cm2, 0.5% 15-ME-PGF2alpha methyl ester intravaginal silastic device on abortion and plasma prostaglandin concentration.
    Lauersen NH; Wilson KH
    Prostaglandins; 1977 Apr; 13(4):755-62. PubMed ID: 857275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical comparison of abortifacient activity of vaginally administered prostaglandin E2 in two dosage forms.
    Roseman TJ; Gutknecht GD; Stehle RG; Southern EM
    Am J Obstet Gynecol; 1977 Sep; 129(2):225-7. PubMed ID: 19973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous extraovular administration of prostaglandin F2alpha for midtrimester abortion.
    Lauersen NH; Wilson KH
    Am J Obstet Gynecol; 1974 Sep; 120(2):273-80. PubMed ID: 4412615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginally administered 16, 16-dimethyl-PGE2 for the induction of midtrimester abortion.
    Martin JN; Bygdeman M; Ramadan M; Gréen K; Leader A; Lundström V; Wiqvist N
    Prostaglandins; 1976 Jan; 11(1):123-32. PubMed ID: 769088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone release and abortifacient effectiveness of a newly developed silastic device containing 15-ME-PGF2alpha methyl ester in concentrations of 0.5% and 1.0%.
    Lauersen NH; Wilson KH
    Prostaglandins; 1976; 12 Suppl():63-79. PubMed ID: 968066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of vaginal prostaglandin-E2 suppositories in septic abortion.
    Milano CT; Gleicher N
    Prostaglandins; 1980 Mar; 19(3):455-6. PubMed ID: 7384552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginally administered prostaglandin E2 as a first and second trimester abortifacient.
    Corson SL; Bolognese RJ
    J Reprod Med; 1975 Feb; 14(2):43-6. PubMed ID: 1113258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
    Robins J; Surrago EJ
    J Reprod Med; 1982 Jul; 27(7):415-9. PubMed ID: 6956734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vaginal administration of 9-deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortion.
    Ballard CA
    Contraception; 1981 Aug; 24(2):151-7. PubMed ID: 7297067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new abortion technique: intravaginal and intramuscular prostaglandin.
    Lauersen NH; Den T; Scher J; Iliescu C; Wilson KH
    Obstet Gynecol; 1981 Jul; 58(1):96-100. PubMed ID: 7243150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-trimester abortion by intramuscular 15-methyl-prostaglandin F2 alpha or intravaginal prostaglandin E2 suppositories: a randomized trial.
    Borgida AF; Rodis JF; Hanlon W; Craffey A; Ciarleglio L; Campbell WA
    Obstet Gynecol; 1995 May; 85(5 Pt 1):697-700. PubMed ID: 7724098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.